Latest Sangamo BioSciences Inc. Stories
Hunter's Disease and Hurler's Disease Named as Sangamo's First Proprietary Programs in Lysosomal Storage Disorders RICHMOND, Calif., Jan. 12, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
mRNA Delivery a Natural Fit for ZFN-mediated Genome Editing Which Requires Only Transient Expression to Achieve a Permanent Therapeutic Effect RICHMOND, Calif., Jan.
RICHMOND, Calif., Jan. 5, 2015 /PRNewswire/ -- Sangamo BioSciences, Inc.
Data Demonstrate Therapeutic Levels of Clotting Factor for Hemophilia in Non-Human Primates and In Vivo Protein Production of Lysosomal Storage Disease Enzymes RICHMOND, Calif., Dec.
Novel ZFP Therapeutic Approach Selectively Represses Expression of Huntington's Disease-Causing Gene Variant in Patient-Derived Cells and Animal Models RICHMOND, Calif., Nov.
ARM and The Medical Technology Caucus to Host a Congressional Briefing Focused on "Meeting Unmet Medical Needs Through Regenerative Medicine" RICHMOND, Calif., Nov.
RICHMOND, Calif., Oct. 16, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
RICHMOND, Calif., Oct. 15, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
Timeline for Hemophilia B IND Application Filing Targeting Second Quarter 2015 RICHMOND, Calif., Sept. 10, 2014 /PRNewswire/ -- Sangamo BioSciences, Inc.
Control of Viral Load During Treatment Interruption of Antiretroviral Therapy Sustained and Ongoing for More than One Year in One Subject and Several Months in Another RICHMOND,
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.